Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Neurosurgery|March 21, 2019
Surgical Performance Determines Functional Outcome Benefit in the Minimally Invasive Surgery Plus Recombinant Tissue Plasminogen Activator for Intracerebral Hemorrhage Evacuation (MISTIE) ProcedureIssam A Awad, Sean P Polster, Julián Carrión-Penagos, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|April 5, 2019
A randomized 500-subject open-label phase 3 clinical trial of minimally invasive surgery plus alteplase in intracerebral hemorrhage evacuation (MISTIE III)Wendy C Ziai, Nichol McBee, Karen Lane, et al.
Neurosurgery|November 27, 2018
Atorvastatin Treatment of Cavernous Angiomas with Symptomatic Hemorrhage Exploratory Proof of Concept (AT CASH EPOC) TrialSean P Polster, Agnieszka Stadnik, Amy L Akers, et al.
Neurosurgery|January 21, 2021
Intracerebral Hemorrhage Volume Reduction and Timing of Intervention Versus Functional Benefit and Survival in the MISTIE III and STICH TrialsSean P Polster, Julián Carrión-Penagos, Seán B Lyne, et al.
Stroke|September 16, 2021
Baseline Characteristics of Patients With Cavernous Angiomas With Symptomatic Hemorrhage in Multisite Trial Readiness ProjectHelen Kim, Kelly D Flemming, Jeffrey A Nelson, et al.
Medrxiv : the Preprint Server for Health Sciences|January 19, 2022
Hydroxychloroquine/chloroquine for the treatment of hospitalized patients with COVID-19: An individual participant data meta-analysisLeon Di Stefano, Elizabeth L Ogburn, Malathi Ram, et al.
Plos One|September 29, 2022
Hydroxychloroquine/chloroquine for the treatment of hospitalized patients with COVID-19: An individual participant data meta-analysisLeon Di Stefano, Elizabeth L Ogburn, Malathi Ram, et al.
The Lancet. Neurology|October 19, 2016
Safety and efficacy of minimally invasive surgery plus alteplase in intracerebral haemorrhage evacuation (MISTIE): a randomised, controlled, open-label, phase 2 trialDaniel F Hanley, Richard E Thompson, John Muschelli, et al.
Transfusion|March 30, 2022
How do I implement an outpatient program for the administration of convalescent plasma for COVID-19?Evan M Bloch, Aaron A R Tobian, Shmuel Shoham, et al.
Contemporary Clinical Trials|May 5, 2026
Conducting multicenter trials through the trial innovation network comprehensive consultationDaniel F Hanley, Karen Lane, Nichol McBee, et al.
Pageof 5